arginyl-glycyl-aspartyl-serine has been researched along with Cirrhosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, R; Luthra-Guptasarma, M; Ram, J; Sharma, M; Tiwari, A | 1 |
| Bos, IS; Dekkers, BG; Gosens, R; Halayko, AJ; Meurs, H; Zaagsma, J | 1 |
2 other study(ies) available for arginyl-glycyl-aspartyl-serine and Cirrhosis
| Article | Year |
|---|---|
Control of fibrotic changes through the synergistic effects of anti-fibronectin antibody and an RGDS-tagged form of the same antibody.
Topics: Cell Proliferation; Cells, Cultured; Cytokines; Drug Synergism; Fibronectins; Fibrosis; Humans; Integrins; Oligopeptides; Pigment Epithelium of Eye; Single-Chain Antibodies | 2016 |
The integrin-blocking peptide RGDS inhibits airway smooth muscle remodeling in a guinea pig model of allergic asthma.
Topics: Administration, Topical; Airway Remodeling; Animals; Antibodies; Asthma; Biomarkers; Blotting, Western; Cell Culture Techniques; Cell Proliferation; Disease Models, Animal; Fibrosis; Guinea Pigs; Humans; Inflammation; Male; Muscle Contraction; Muscle, Smooth; Oligopeptides; Platelet Aggregation Inhibitors; Proliferating Cell Nuclear Antigen | 2010 |